Dr. Jyoti Taneja

Dr. Jyoti Taneja is a distinguished researcher specializing in reproductive health and infectious disease epidemiology, with a strong emphasis on polycystic ovary syndrome (PCOS) and menstrual health. Her work has been instrumental in uncovering the intricate relationship between lifestyle in women’s reproductive health.

In addition to her contributions to reproductive health, Dr. Taneja is actively involved in machine learning applications in disease biology and vaccine development, leveraging AI-driven approaches to enhance diagnostic precision and therapeutic advancements.

Her expertise extends to infectious disease epidemiology, where she has played a significant role in understanding COVID-19 dynamics, addressing critical public health challenges such as disease severity, breakthrough infections, post-COVID sequelae, and vaccine hesitancy. Her research has been widely published in leading scientific journals, contributing to data-driven public health policies and interventions.

Currently, Dr. Taneja is leading a CSIR-funded project on post-COVID sequelae symptoms, aiming to advance knowledge on long-term health implications of the virus. Through her interdisciplinary approach, she continues to bridge the gap between research, healthcare policy, and technological innovation, driving progress in women’s health, infectious disease management, and global public health preparedness.